comparemela.com

Latest Breaking News On - Amneal - Page 1 : comparemela.com

Amneal Expands Oncology Offering With Two Denosumab Biosimilars - Life Sciences, Biotechnology & Nanotechnology

On October 12, Amneal announced that it will be adding two denosumab biosimilars to its oncology pipeline, referencing PROLIA and XGEVA.

Amneal Stock Rises 21% After Q2 Profit Beats Estimates, Raises Guidance

Shares of Amneal Pharmaceuticals, Inc. (AMRX) are rising 21 percent on Friday after turning to profit in the second quarter, compared to a loss last year and also beat estimates.

Amneal to Participate at the 2023 Jefferies Healthcare Conference

Amneal Pharmaceuticals, Inc. today announced that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate at the 2023 Jefferies. | May 24, 2023

Amneal: Q1 Earnings Snapshot | MarketScreener

BRIDGEWATER, N.J. — BRIDGEWATER, N.J. — Amneal Pharmaceuticals, Inc. on Friday reported a loss of $6.9 million in its first quarter. On a per-share basis, the Bridgewater, New. | May 5, 2023

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.